Interchangeable Biosimilars and Pharmacy-Level Substitution Drive Adoption in Immunology
The global Humira Biosimilars Market is projected to increase from USD 9.6 billion in 2026 to USD 23.8 billion by 2036, registering a compound annual growth rate (CAGR) of 9.5%, according to Future Market Insights (FMI). Growth is supported by healthcare systems transitioning patients from the reference biologic to lower-cost adalimumab alternatives, alongside wider availability of...
0 Σχόλια 0 Μοιράστηκε 2 Views 0 Προεπισκόπηση
social art-inpa https://social.art-inpa.com